Literature DB >> 8866497

Hashimoto's myoclonic encephalopathy: an underdiagnosed treatable condition?

F Ghika-Schmid1, J Ghika, F Regli, N Dworak, J Bogousslavsky, C Städler, L Portmann, P A Despland.   

Abstract

We report two patients with subacute diffuse encephalopathy characterized by confusion, myoclonic encephalopathy, and mild akineto-rigid extrapyramidal signs in one case and by apathy, memory deficit, and partial complex seizures in the other. Hashimoto's thyroiditis with high titers of anti-thyroglobulin antibodies was diagnosed in both patients, who were unresponsive to anticonvulsant medication, but showed rapid neurological improvement following steroid treatment. On neuropsychological examination, predominant frontotemporal dysfunction was noted. Electroencephalographic activity was remarkable for its rhythmical delta activity, unresponsive to, or even paradoxically increased by, anticonvulsant treatment. On magnetic resonance imaging, atrophy with temporal predominance was found. These observations support the idea that this potentially treatable dementia and movement disorder should be classified as a separate clinical entity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8866497     DOI: 10.1002/mds.870110511

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  12 in total

1.  Hashimoto's encephalitis as a differential diagnosis of Creutzfeldt-Jakob disease.

Authors:  M Seipelt; I Zerr; R Nau; B Mollenhauer; S Kropp; B J Steinhoff; C Wilhelm-Gössling; C Bamberg; R W Janzen; P Berlit; F Manz; K Felgenhauer; S Poser
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-02       Impact factor: 10.154

Review 2.  Clinical and diagnostic aspects of encephalopathy associated with autoimmune thyroid disease (or Hashimoto's encephalopathy).

Authors:  Gianluca Tamagno; Giovanni Federspil; Giovanni Murialdo
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

Review 3.  The neurological disorder associated with thyroid autoimmunity.

Authors:  Franco Ferracci; Antonio Carnevale
Journal:  J Neurol       Date:  2006-06-19       Impact factor: 4.849

4.  Steroid-responsive Hashimoto encephalopathy mimicking Creutzfeldt-Jakob disease.

Authors:  Domenico Santoro; Irene Colombo; Isabella Ghione; Lorenzo Peverelli; Nereo Bresolin; Monica Sciacco; Alessandro Prelle
Journal:  Neurol Sci       Date:  2011-05-10       Impact factor: 3.307

5.  Immunotherapy responsive autoimmune subacute encephalitis: a report of two cases.

Authors:  Manoj Mittal; Nancy Hammond; Sharon G Lynch
Journal:  Case Rep Med       Date:  2010-03-18

Review 6.  Rapidly progressive dementia.

Authors:  Michael D Geschwind; Aissa Haman; Bruce L Miller
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

Review 7.  Cerebellar Syndrome Associated with Thyroid Disorders.

Authors:  Tommaso Ercoli; Giovanni Defazio; Antonella Muroni
Journal:  Cerebellum       Date:  2019-10       Impact factor: 3.847

8.  A series report of autoimmune hypothyroidism associated with Hashimoto's encephalopathy: an under diagnosed clinical entity with good prognosis.

Authors:  Hemanta Kumar Nayak; Mrudul Kumar Daga; Rakshit Kumar; Sandeep Kumar Garg; Naresh Kumar; Pankaj Kumar Mohanty
Journal:  BMJ Case Rep       Date:  2010-11-23

9.  Limbic encephalitis associated with anti-NH2-terminal of α-enolase antibodies: A clinical subtype of Hashimoto encephalopathy.

Authors:  Toru Kishitani; Akiko Matsunaga; Masamichi Ikawa; Kouji Hayashi; Osamu Yamamura; Tadanori Hamano; Osamu Watanabe; Keiko Tanaka; Yasunari Nakamoto; Makoto Yoneda
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

10.  Spectroscopic correlation and role of Azathioprine in long-term remission in patients of Hashimoto encephalopathy.

Authors:  Harpreet Singh; Sucharita Ray; Shalini Agarwal; Raj Pal Verma; Paulomi Talapatra; Vikas Gupta
Journal:  Ann Indian Acad Neurol       Date:  2013-07       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.